Glycorex Transplantation (GTAB B): Glycorex Technology Validated in Transfusion – New Study Demonstrates Effective Production of Universal Platelets
Lund, Sweden – Glycorex Transplantation AB (publ) today announces that the scientific journal Transfusion has published an independent study conducted by NHS Blood and Transplant (NHSBT) and the University of Cambridge. The study demonstrates that Glycosorb® ABO effectively reduces blood group antibodies in platelet units to safe levels without significant cell loss.
Platelet shortages and a short shelf life (5–7 days) present major logistical challenges for healthcare systems. In emergency situations or when matched blood is unavailable, ABO-incompatible platelets are frequently transfused,